Skip to content
Search

Latest Stories

Majority of COVID-19 victims in India are aged over 60 years

THE COVID-19 pandemic has proved to be fatal for those aged above 60 years in India, data  showed.

Those above 60 years of age make up just 19% of coronavirus cases in the country, but the death rate is quite high at 63 per cent.


About 86 per cent of dead had conditions such as diabetes, hyperteension, heart and kidney diseases, health ministry data showed.

Te death toll due to the COVID-19 pandemic rose to 114 and the number of infections climbed to 4,421 in the country.

The active COVID-19 cases stood at 3,851, while 318 people were either cured or discharged and one had migrated, the ministry stated.

According to health ministry data, 30 per cent of those who died were 40-60 years old and only seven per cent were younger than 40.

In India, men are more vulnerable to the infection than women.

Out of the total cases 76 per cent are men. In total number of deaths men accounted for 73 per cent.

The highest number of confirmed cases are from Maharashtra (748), followed by Tamil Nadu at 571 and Delhi with 523 cases.

More For You

OpenAI acquires Torch

OpenAI is expanding its healthcare ambitions by adding medical data technology to its AI platform

X handle/Ilya Abyzov

OpenAI acquires health tech startup Torch in push into medical AI

  • OpenAI acquires Torch for about £47 million ($60 million)
  • Torch staff to join OpenAI after the deal
  • Move comes days after ChatGPT Health rollout

OpenAI has acquired healthcare technology startup Torch for roughly £47 million ($60 million), according to CNBC, citing a source familiar with the deal. The price was not disclosed publicly, but the acquisition points to a stronger push by OpenAI into medical artificial intelligence.

The deal comes just days after OpenAI rolled out ChatGPT Health, a new experience designed to help users engage with health-related information in a more personalised way. The timing suggests the company is moving quickly to build infrastructure around medical data rather than relying only on general-purpose AI tools.

Keep ReadingShow less